Потенциальные возможности применения нутрицевтических продуктов с целью пролонгирования ремиссии у пациентов с синдромом раздраженного кишечника
https://doi.org/10.22416/1382-4376-2018-28-2-101-108
Аннотация
Об авторах
А. И. Ульянин
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» (Сеченовский университет)
Россия
Россия
Е. А. Полуэктова
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» (Сеченовский университет)
Россия
Россия
Ч. С. Павлов
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» (Сеченовский университет)
Россия
Россия
В. Т. Ивашкин
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» (Сеченовский университет)
Россия
Россия
Список литературы
1. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012;13:701-12.
2. Cash B.D., Chey W.D. Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther 2005;11:1047-60.
3. Clarke G., Cryan J.F., Dinan T.G. et al. Review article: probiotics for the treatment of irritable bowel syndrome - focus on lactic acid bacteria. Aliment Pharmacol Ther 2012;35:403-13.
4. Tillisch K., Labus J., Kilpatrick L. et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013;144:1394-401.
5. Jeffery I.B., O’Toole P.W., Öhman L., Claesson M.J., Deane J., Quigley E.M., Simrén M. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012;61(7):997-1006.
6. Pozuelo M., Panda S., Santiago A. Reduction of butyrate and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep 2015;5:12693.
7. Spiller R., Lam C. An update on post-infectious irritable bowel syndrome: role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil 2012;18:258-68.
8. Harris L.A., Baffy N. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome. Postgrad Med 2017;129(8):872-88.
9. Hua Chu, Mark Fox, Xia Zheng et al. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract 2016;2016:3230859.
10. Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal et al. The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe? Int J Inflam 2012; 2012:151085.
11. An S., Zong G., Wang Z., Shi J., Du H., Hu J. Expression of inducible nitric oxide synthase in mast cells contributes to the regulation of inflammatory cytokines in irritable bowel syndrome with diarrhea. J Neurogastroenterol Motil 2016; 28(7):1083-93.
12. Cremon C., Gargano L., Morselli-Labate A.M., Santini D., Cogliandro R.F., De Giorgio R., Stanghellini V., Corinaldesi R., Barbara G. Mucosal immune activation in irritable bowel syndrome: genderdependence and association with digestive symptoms. Am J Gastroenterol 2009;104:392-400.
13. O’Malley D. Neuroimmune Cross Talk in the Gut. Neuroendocrine and neuroimmune pathways contribute to the pathophysiology of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2016;311(5):934-41.
14. Kurbatova A., Poluektova E., Demura T., Kuchumova S., Konkov M., Gorev M., Sheptulin A., Kogan E., Shifrin O., Ivashkin V. Cytokines and tight junction proteins expression changes in patients with irritable bowel syndrome. Gastroenterology 2013; 142(5, Suppl 1):807.
15. Romero-Valdovinos M., Gudiño-Ramírez A., ReyesGordillo J. Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome. Biol Rep 2012;39:8837-43.
16. Ивашкин В.Т., Полуэктова Е.А. Функциональные расстройства желудочно-кишечного тракта. М.: МЕДпрессинформ; 2013. 127 с.
17. Cash B.D., Chey W.D. Review article: The role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther 2005;22(11):1047-60.
18. Katsui R. et al. A new possibility for repairing the anal dysfunction by promoting regeneration of the reflex pathways in the enteric nervous system. Am J Physiol Gastrointest Liver Physiol 2008; 294:1084-93.
19. Gershon M.D. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel. J Clin Gastroenterol 2005;39(5, Suppl 3):184-93.
20. Fichna J., Poole D., Veldhuis N. Transient receptor potential vanilloid 4 inhibits mouse colonic motility by activating NO-dependent enteric neurotransmission. J Mol Med (Berl) 2015;93(12):1297-309.
21. Sarkar A., Lehto S.M., Harty S., Dinan T.G., Cryan J.F., Burnet P.W. Psychobiotics and the Manipulation of Bacteria-Gut-Brain Signals. Trends Neurosci 2016;39(11):763-81.
22. Barrett E., Ross R.P., O’Toole P.W., Fitzgerald G.F., Stanton C. g-Aminobutyric acid production by culturable bacteria from the human intestine J Appl Microbiol 2012;113(2):411-7.
23. Mei-Lin Tsai, Chin-Tung Wu, Tsen-Fang Lin, WeiChao Lin, Yu-Chun Huang, Chao-Hsun Yang. Chemical Composition and Biological Properties of Essential Oils of Two Mint Species. Tropical J Pharmaceutical Res 2013; 12(4): 577-82.
24. Hawthorn M., Ferrante J., Luchowski E., Rutledge A., We X.Y., Triggle D.J. The actions of peppermint oil and menthol on calcium channel dependenf processes in intestinal, neuronal and cardiac preparations. Aliment Pharmacol Ther 1988; 2:101-18.
25. Hills J.M., Aaronson P.I. The Mechanism of Action of Peppermint Oil on Gastrointestinal Smooth Muscle. Gastroenterology 1991;101: 55-65.
26. Amatoa A., Liottab R., Mulèa F. Effects of menthol on circular smooth muscle of human colon: Analysis of the mechanism of action. Eur J Pharmacol 2014;740: 295-301.
27. Ghasemi-Pirbalutia M., Motaghib E., Bozorgic H. The effect of menthol on acute experimental colitis in rats. Eur J Pharmacol 2017;15;805:101-7.
28. Galeottia N., Di Cesare Mannellia L., Mazzantib G., Bartolinia A., Ghelardinia C. Menthol: a natural analgesic compound. Neurosci Lett 2002;12;322(3):145-8.
29. Rozza A.L., Meira de Faria F., Souza Brito A.R., Pellizzon C.H. The gastroprotective effect of menthol: involvement of anti-apoptotic, antioxidant and antiinflammatory activities. PLoS One 2014;9(1):e86686.
30. Gaudioso C., Hao J., Martin-Eauclaire M.F., Gabriac M., Delmas P. Menthol pain relief through cumulative inactivation of voltage-gated sodium channels. Pain 2012;153(2):473-84.
31. Xue J., Li H., Deng X., Ma Z., Fu Q., Ma S. L-Menthone confers antidepressant-like effects in an unpredictable chronic mild stress mouse model via NLRP3 inflammasome-mediated inflammatory cytokines and central neurotransmitters. Pharmacol Biochem Behav 2015;134:42-8.
32. Xiao-Bing Zhang Peng Jiang, Neng Gong, Xiao-Ling Hu, Da Fei, Zhi-Qi Xiong, Lin Xu, Tian-Le Xu. A-Type GABA Receptor as a Central Target of TRPM8 Agonist Menthol. PLoS One 2008; 3(10):e3386.
33. Imai H., Osawa K., Yasuda H., Hamashima H., Arai T., Sasatsu M. Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria. Microbios 2001;106 (Suppl 1):31-9.
34. Brooks D. Cash, Michael S. Epstein, Syed M. Shah. A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms. Dig Dis Sci 2016; 61:560-71.
35. Moraes T.M. et al. Healing actions of essential oils from Citrus aurantium and d-limonene in the gastric mucosa: the roles of VEGF, PCNA, and COX-2 in cell proliferation. J Med Food 2013;16(12):1162-7.
36. Ahmed R.S, Suke S.G, Seth V., Chakraborti A., Tripathi A.K., Banerjee B.D. Protective effects of dietary ginger (Zingiber officinales Rosc.) on lindane-induced oxidative stress in rats. Phytother Res 2008;22(7):902-6.
37. Ippoushi Kl., Ito H., Horie H., Azuma K. Mechanism of inhibition of peroxynitrite-induced oxidation and nitration by [6]-gingerol. Planta Med 2005;71(6):563-6.
38. Lee T.Y., Lee K.C., Chen S.Y., Chang H.H. [6]-gingerol inhibits ROS and iNOS through the sup-pressionof PKCalpha and NF-kappaB pathways in lipopolysaccharidestimulated mouse macrophages. Biochem Biophys Res Commun 2009;382(1):134-9.
39. Pongrojpaw D., Chiamchanya C. The efficacy of ginger in prevention of post-operative nausea and vomiting after outpatient gynecological laparoscopy. J Med Assoc Thai 2003;86(3):244-50.
40. Gupta Y.K., Sharma M. Reversal of pyrogallolinduced delay in gastric emptying in rats by ginger (Zingiber officinale). Methods Find Exp Clin Pharmacol 2001;23(9):501-3.
41. Ghayur et al. Ginger facilitates cholinergic activity possibly due to blockade of muscarinic autoreceptors in rat stomach fundus. Pak J Pharm Sci 2007;20(3):231-5.
42. Zheng-Xu Cai et al. Effect of gingerol on colonic motility via inhibition of calcium channel currents in rats. World J Gastroenterol 2015; 21(48):13466-72.
43. Giacosa A., Morazzoni P., Bombardelli E., Riva A., Bianchi Porro G., Rondanelli M. Can nausea and vomiting be treated with ginger extract? Eur Rev Med Pharmacol Sci 2015;19(7):1291-6.
44. Portnoi G., Chng L.A., Karimi-Tabesh L., Koren G., Tan M.P., Einarson A. Prospective compara-tive study of the safety and effectiveness of ginger for the treatment of nausea and vomiting in pregnancy. Am J Obstet Gynecol 2003;189(5):1374-7.
45. Willetts K.E, Ekangaki A., Eden J.A. Effect of a ginger extract on pregnancy-induced nausea: A randomised controlled trial. Aust N Z J Obstet Gynaecol 2003;43(2):139-44.
46. Ashis Kumar Samanta, Jayaram C., Jayapal N., Sondhi N., Kolte A.P., Senani S., Sridhar M., Dhali A. Assessment of Fecal Microflora Changes in Pigs Supplemented with Herbal Residue and Prebiotic. PLoS One 2015; 10(7): e0132961.
47. Ивашкин В.Т., Шептулин А.А., Полуэктова Е.А., Рейхарт Д.В., Белостоцкий А.В., Дроздова А.А., Арнаутов В.С. Возможности применения Опросника «7×7» (7 симптомов за 7 дней) для оценки динамики симптомов функциональной диспепсии и синдрома раздраженного кишечника. Рос журн гастроэнтерол гепатол колопроктол 2016;26(3):24-33.
Рецензия
Для цитирования:
Ульянин А.И., Полуэктова Е.А., Павлов Ч.С., Ивашкин В.Т. Потенциальные возможности применения нутрицевтических продуктов с целью пролонгирования ремиссии у пациентов с синдромом раздраженного кишечника. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2018;28(2):101-108. https://doi.org/10.22416/1382-4376-2018-28-2-101-108
For citation:
Ulyanin A.I., Poluektova Ye.A., Pavlov Ch.S., Ivashkin V.T. Potential of nutraceutical products for irritable bowel syndrome remission maintenance. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(2):101-108. (In Russ.) https://doi.org/10.22416/1382-4376-2018-28-2-101-108
Просмотров: 1033
Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Послать статью по эл. почте 
